Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Molecules/ABATACEPT

ABATACEPT

CHEMBL1201823
Compare

Molecular Identity

ABATACEPT

ChEMBL ID: CHEMBL1201823

ProteinApprovedFirst approved 2006

Mechanism of action: T-lymphocyte activation antigen CD86 inhibitor

Properties

Molecular Formula
0.00
Molecular Weight
g/mol

Synonyms(9)

ABATACEPTABATACEPT (GENETICAL RECOMBINATION)ABATACEPT RECOMBINANTBMS-188667CTLA4-IGG4MORENCIAORENCIA CLICKJECTRG-1046RG-2077
Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to ABATACEPT

Loading drug network...